Citation only
via OpenAlex
Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy
Shinji Kume, Munehiro Kitada, Keizo Kanasaki, Hiroshi Maegawa, Daisuke Koya
Archives of Pharmacal Research · 2013 · ▲ 68 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s12272-013-0019-4
- Canonical
- link ↗
- Fetched
- 2026-06-15 MST
Cite this
APA
Kume, S., Kitada, M., Kanasaki, K., Maegawa, H., & Koya, D. (2013). Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy. <em>Archives of Pharmacal Research</em>. https://doi.org/10.1007/s12272-013-0019-4
Vancouver
Kume S, Kitada M, Kanasaki K, Maegawa H, Koya D. Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy. Archives of Pharmacal Research. 2013. doi:10.1007/s12272-013-0019-4.
BibTeX
@article{shinji2013Antiag,
title = {Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy},
author = {Shinji Kume and Munehiro Kitada and Keizo Kanasaki and Hiroshi Maegawa and Daisuke Koya},
journal = {Archives of Pharmacal Research},
year = {2013},
doi = {10.1007/s12272-013-0019-4},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Preventive Medicine 2011
Preprint · OA
SIRT1 as a therapeutic target in inflammaging of the pulmonary disease
Nature Reviews Disease Primers 2019
Open access · OA
Diabetic neuropathy
Pharmacology & Therapeutics 2019
Preprint · CC-BY
Autophagy as a novel therapeutic target in vascular calcification
Molecular Aspects of Medicine 2007
Citation only
SIRT1 and neuronal diseases
Cell 2012
Open access · OA
Diabetic β Cells: To Be or Not To Be?
Nature Reviews Drug Discovery 2019
Open access · OA